In an open-label proof-of-concept trial (N=5), psilocybin-assisted therapy was well tolerated in adults with fibromyalgia, producing only transient elevations in blood pressure/heart rate and non-serious post-dose headaches. Participants showed clinically meaningful improvements in pain severity, pain interference and sleep disturbance one month after treatment, supporting progression to larger randomised controlled trials.
- Published
- Journal
- Frontiers in Pain Research
- Authors
- Aday, J. S., Baker, A. K., Boehnke, K. F., Burgess, H. J., Clauw, D. J., Conroy, D. A., Davis, A. K., Glynos, N., Guss, J., Harte, S. E., Horowitz, D., Hosanagar, A., Mashour, G. A., McAfee, J., Pouyan, N., Scott, K., Tarnal, V., Weston, C.